Screening for pre-eclampsia by maternal serum glycosylated fibronectin and angiogenic markers at 36 weeks' gestation.

Sokratous, N; Wright, A; Syngelaki, A; Kakouri, E; Laich, A; Nicolaides, K H

Sokratous, N; Wright, A; Syngelaki, A; Kakouri, E; Laich, A; Nicolaides, K H.

Afiliación

Sokratous N; Fetal Medicine Research Institute, King's College Hospital, London, UK.
Wright A; Institute of Health Research, University of Exeter, Exeter, UK.
Syngelaki A; Fetal Medicine Research Institute, King's College Hospital, London, UK.
Kakouri E; Institute of Women and Children's Health, School of Life Course and Population Sciences, King's College London, London, UK.
Laich A; Fetal Medicine Research Institute, King's College Hospital, London, UK.
Nicolaides KH; Fetal Medicine Research Institute, King's College Hospital, London, UK.

Ultrasound Obstet Gynecol ; 63(1): 88-97, 2024 01.

Article en En | MEDLINE | ID: mdl-37724582

Asunto(s)

Hipertensión Inducida en el Embarazo; Preeclampsia; Embarazo; Femenino; Humanos; Factor de Crecimiento Placentario; Edad Gestacional; Estudios Prospectivos; Estudios de Casos y Controles; Biomarcadores; Arteria Uterina; Flujo Pulsátil; Receptor 1 de Factores de Crecimiento Endotelial Vascular; Valor Predictivo de las Pruebas

Palabras clave

angiogenic factor; antiangiogenic factor; competing-risks model; glycosylated fibronectin; mean arterial pressure; placental growth factor; pre-eclampsia; soluble fms-like tyrosine kinase-1; survival model; third-trimester screening; uterine artery Doppler

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Preeclampsia / Hipertensión Inducida en el Embarazo Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Female / Humans / Pregnancy Idioma: En Año: 2024 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google